510(k) K051072

BIO-RAD VARIANT NBS SICKLE CELL PROGRAM by Bio-Rad Laboratories, Inc. — Product Code GKA

K051072 is an FDA 510(k) premarket notification submitted by Bio-Rad Laboratories, Inc. for the device "BIO-RAD VARIANT NBS SICKLE CELL PROGRAM". The FDA issued a decision of Substantially Equivalent on May 12, 2005. The device falls under product code GKA (Abnormal Hemoglobin Quantitation), a Class II device regulated under 21 CFR 864.7415. Bio-Rad Laboratories, Inc. has 127 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 12, 2005
Date Received
Apr 26, 2005
Clearance Type
Traditional
Expedited Review
No
Third Party Review
Yes

Device classification

Device Name
Abnormal Hemoglobin Quantitation
Device Class
Class II
Regulation Number
864.7415
Review Panel
HE
Submission Type
510(k)

Need the full FDA record for Bio-Rad Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K051072. Report a data issue: hello@regdatalab.com.